Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
1-<4
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
0.5-<2
EC/CAS
7631-86-9
Name of the chemical
Silver adsorbed on silicon dioxide
Concentration
0.2-<0.3
EC/CAS
68921-42-6
Name of the chemical
Benzenemethanaminium, N-ethyl-N-[4-[[4-[ethyl-[(3-sulfophenyl)-methyl]-amino]-phenyl](2-sulfophenyl)methylene]-2,5-cyclohexadien-1-ylidene]-3-sulfo, inner salts, disodium salt and its ammonium and aluminium salts (17); (CI 42090)
Concentration
0.1-<0.7
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
2.8
General Information
Revision date
2022-05-25
Product name
VALTREX CAPLETS
Product Synonyms
VALTREX FILM-COATED CAPSULE-SHAPED TABLETS * VALTREX CAPLETS 500 MG * VALTREX CAPLETS 1000 MG * VALACYCLOVIR HYDROCHLORIDE, FORMULATED PRODUCT
Emergency telephone
+1-888-825-5249, +(1) 760 476 3971, +(1) 760 476 3962, +(1) 866 519 4752
Icons in SDS
Company Information
company name
GlaxoSmithKline US
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
Physical hazards
Not classified
Health hazards
Acute toxicity, oral Category 4
Environmental hazards
Not classified
Signal word
Warning
Hazard statements
Harmful if swallowed.
Prevention
Wash thoroughly after handling. Do not eat, drink or smoke when using this product.
Response
If swallowed: Call a poison center/doctor// if you feel unwell. Rinse mouth.
Storage
Not available.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations. Hazard(s) not otherwise Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health classified (HNOC) hazards
Additional information
12.6% of the mixture consists of component(s) of unknown acute oral toxicity. 93.4% of the mixture consists of component(s) of unknown acute dermal toxicity. 93.4% of the mixture consists of component(s) of unknown acute inhalation toxicity. 87% of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 87% of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.1 Classification of the substance or mixture
Not classified. Health hazards Acute toxicity, oral Category 4 Environmental hazards Not classified. OSHA defined hazards Not classified.